Yang Yu-Chen, Mao Jian, Li Juan
Department of Neonatology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Jan;20(1):67-71. doi: 10.7499/j.issn.1008-8830.2018.01.014.
Bronchopulmonary dysplasia (BPD) is the most common long-term complication in surviving extremely preterm infants. This may lead to pulmonary hypertension, increase late neonatal mortality, and cause abnormal neural development. There is still controversy over the efficacy, as well as advantages and disadvantages, of drug therapy for BPD in preterm infants. This article reviews the research progress in the drug therapy for BPD.
支气管肺发育不良（BPD）是存活的极早产儿最常见的长期并发症。这可能导致肺动脉高压，增加新生儿晚期死亡率，并引起神经发育异常。关于早产儿BPD药物治疗的疗效以及利弊仍存在争议。本文综述了BPD药物治疗的研究进展。
